SANOFINSESanofi India Limited· PharmaceuticalsMediumNeutral
Announced Tue, 21 Apr · 18:33 IST

Sanofi India Limited has informed the Exchange about disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Refund Order

Regulatory & Legal View source PDF

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.8%1-day move
₹3584.00
prior close
₹3545.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.8-0.7-0.1-3.8-4.5-4.4-3.5-4.4-5.1-9.3-11.9-7.0-4.8
Up moveDown movePending
AI summary

The Assistant Commissioner of Central GST, Vadodara, has issued a refund order for the period August 2014 to June 2017. The order partially accepts Sanofi India's submissions and grants a refund of Rs. 52.08 lakh, comprising Rs. 33.97 lakh as principal and Rs. 18.11 lakh as interest. However, a refund claim of Rs. 11.63 lakh has been denied. The company had originally filed for a refund of Rs. 45.60 lakh related to a pre-deposit paid during an earlier appeal that was decided in its favour. Sanofi India intends to file an appeal before the appellate authorities for the ungranted portion of the refund.

Likely market impact

This is a routine tax refund development with a minor positive cash inflow of Rs. 52 lakh; the small denied portion is immaterial and will be pursued through appeal, so minimal impact on shareholders or stock price.